An underground economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.
Investigational Drug Acquiring Traction Online
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to contact these accounts directly for source information, while also receiving discount codes.
Thriving Trade on Social Networks
Separately, a flourishing trade exists on Telegram, where groups with thousands of members share comparison images, injection guides and assertions of next-day British shipping. Vendors promote the drug there before directing customers to WhatsApp for transactions.
Learning About The Experimental Drug
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Medical Professionals Express Concerns
Nevertheless, physicians and pharmacists have cautions that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could result in individuals injecting substances of uncertain source.
Several professionals said the popularity for the experimental drug could be connected to the increasing price of approved slimming treatments such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach pharmaceutical, marketing, and consumer regulations, potentially leading to fines, prosecution or prison.
Service Reaction and Content Elimination
According to TikTok, the service has taken down problematic material and banned associated keywords and search suggestions. The company said it was dedicated to keeping the platform secure and allocating resources in strengthening compliance measures.
Digital Marketplace Activities
Research also found communities with up to 9,000 participants selling retatrutide using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately brings up groups with thousands of users, filled with photos of weight loss, positive reviews and detailed guides for mixing or administering at home.
Within minutes of joining one community, a seller posted WhatsApp details, where most transactions take place. The vendor provided an guidebook and guaranteed shipping within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about weight, health issues or past usage.
Product Information and Pricing
Within these communities, posts show black plastic packages with Royal Mail stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled injectors usually sold at £160 for 20mg. When asked how much time a pen should be used, vendors give conflicting responses varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for the messaging service stated it actively monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering materials they cannot confirm. Although the research behind retatrutide is valid, these online versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the increase in interest to current cost increases for approved slimming medications such as Mounjaro. “With prices rising, patients are using social media. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.
Her staff has previously seen individuals harmed by self-injection from unverified sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly experimental substance not yet approved … may expose users to potentially serious medical dangers”.
